Collegium Pharma (COLL) Reports Q4 Loss of $1.02/Share
Tweet
Share
E-mailGet Alerts COLL Hot Sheet
Join SI Premium – FREE
Collegium Pharma (NASDAQ: COLL) reported Q4 EPS of ($1.02), versus ($0.46) reported last year.
For earnings history and earnings-related data on Collegium Pharma (COLL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Ennis (EBF) Reports In-Line Q1 EPS
- Korn Ferry (KFY) Tops Q4 EPS by 2c, Beats on Revenue; Offers Q1 Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
